Andrew Quon
Overview
Explore the profile of Andrew Quon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
99
Citations
2306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rauscher I, Fendler W, Hope T, Quon A, Nekolla S, Calais J, et al.
J Nucl Med
. 2019 Jul;
61(2):189-193.
PMID: 31324710
Our purpose was to define a clinically useful lower limit of injected dose for Ga-prostate-specific membrane antigen (PSMA)-11 PET/CT imaging of prostate cancer. Ga-PSMA-11 PET/CT was performed on 11 patients....
12.
Hiniker S, Sodji Q, Quon A, Gutkin P, Arksey N, Graves E, et al.
Front Oncol
. 2019 Jun;
9:467.
PMID: 31214507
Differentiating local recurrence from post-treatment changes on PET scans following stereotactic ablative radiotherapy (SABR) or hyperfractionation for lung tumors is challenging. We performed a prospective pilot study of 3-deoxy-3-[F]-fluorothymidine (FLT)-PET-CT...
13.
Bakr S, Gevaert O, Echegaray S, Ayers K, Zhou M, Shafiq M, et al.
Sci Data
. 2018 Oct;
5:180202.
PMID: 30325352
Medical image biomarkers of cancer promise improvements in patient care through advances in precision medicine. Compared to genomic biomarkers, image biomarkers provide the advantages of being non-invasive, and characterizing a...
14.
Lahiji A, Jackson T, Nejadnik H, von Eyben R, Rubin D, Spunt S, et al.
Mol Imaging Biol
. 2018 Sep;
21(3):591-598.
PMID: 30187233
Purpose: To evaluate whether the extent of restricted diffusion and 2-deoxy-2-[F] fluoro-D-glucose ([F]FDG) uptake of pediatric rhabdomyosarcomas (RMS) on positron emission tomography (PET)/magnetic resonance (MR) images provides prognostic information. Procedure:...
15.
Zhang W, Bouchard G, Yu A, Shafiq M, Jamali M, Shrager J, et al.
Cancer Res
. 2018 May;
78(13):3445-3457.
PMID: 29760045
Metabolic reprogramming of the tumor microenvironment is recognized as a cancer hallmark. To identify new molecular processes associated with tumor metabolism, we analyzed the transcriptome of bulk and flow-sorted human...
16.
Calais J, Fendler W, Eiber M, Gartmann J, Chu F, Nickols N, et al.
J Nucl Med
. 2017 Dec;
59(3):434-441.
PMID: 29242398
In this prospective survey of referring physicians, we investigated whether and how Ga-labeled prostate-specific membrane antigen 11 (Ga-PSMA-11) PET/CT affects the implemented management of prostate cancer patients with biochemical recurrence...
17.
Minamimoto R, Jamali M, Gevaert O, Echegaray S, Khuong A, Hoang C, et al.
Oncotarget
. 2017 Sep;
8(32):52792-52801.
PMID: 28881771
This study investigated the relationship between epidermal growth factor receptor () and Kirsten rat sarcoma viral oncogene homolog () mutations in non-small-cell lung cancer (NSCLC) and quantitative FDG-PET/CT parameters including...
18.
Gensheimer M, Hong J, Chang-Halpenny C, Zhu H, Eclov N, To J, et al.
Radiother Oncol
. 2017 Aug;
125(2):338-343.
PMID: 28830717
Background And Purpose: Pre- and mid-radiotherapy FDG-PET metrics have been proposed as biomarkers of recurrence and survival in patients treated for stage III non-small cell lung cancer. We evaluated these...
19.
Muehe A, Theruvath A, Lai L, Aghighi M, Quon A, Holdsworth S, et al.
Mol Imaging Biol
. 2017 Jul;
20(2):324-335.
PMID: 28721605
Purpose: To provide clinically useful gadolinium-free whole-body cancer staging of children and young adults with integrated positron emission tomography/magnetic resonance (PET/MR) imaging in less than 1 h. Procedures: In this...
20.
Calais J, Czernin J, Eiber M, Fendler W, Gartmann J, Heaney A, et al.
J Nucl Med
. 2017 May;
58(11):1793-1796.
PMID: 28473600
In this prospective referring-physician-based survey, we investigated the definite clinical impact of Ga-DOTATATE PET/CT on managing patients with neuroendocrine tumors (NETs). We prospectively studied 130 patients with Ga-DOTATATE PET/CT referred...